Detalles de la búsqueda
1.
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 68(4): e0108123, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376189
2.
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.
Antimicrob Agents Chemother
; 67(8): e0041423, 2023 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37428034
3.
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
Antimicrob Agents Chemother
; 66(3): e0220321, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35041509
4.
Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.
J Antimicrob Chemother
; 77(7): 1923-1930, 2022 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470370
5.
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model.
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32366710
6.
Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics.
mSystems
; 9(5): e0009324, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38606960
7.
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.
Int J Antimicrob Agents
; 63(6): 107161, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561094
8.
Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease.
Eur J Pharm Biopharm
; 189: 240-250, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354997
9.
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model.
Antibiotics (Basel)
; 11(1)2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35052977
10.
Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model.
J Glob Antimicrob Resist
; 26: 55-63, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023531
11.
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance.
Clin Pharmacol Ther
; 109(4): 1104-1115, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33550617
Resultados
1 -
11
de 11
1
Próxima >
>>